PAPAIJV
ZBH icon

Paragon Associates & Paragon Associates II Joint Venture’s Zimmer Biomet ZBH Stock Holding History

Paragon Associates & Paragon Associates II Joint Venture’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,450
Closed -$1.81M – 21
2017
Q4 		$1.81M Hold
15,450
– – 1.51% 17
2017
Q3 		$1.76M Buy
+15,450
New +$1.78M 1.5% 18

Other funds holding ZBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Paragon Associates & Paragon Associates II Joint Venture's ZBH Position: Q1 2018 in Review

Paragon Associates & Paragon Associates II Joint Venture sold out of Zimmer Biomet (ZBH) in Q1 2018, closing a stake of 15,450 shares — an estimated $1.81M sold.

Paragon Associates & Paragon Associates II Joint Venture first reported a position in ZBH in Q3 2017 and held it in 2 quarters. The position peaked at $1.81M in Q4 2017. 876 funds tracked by Wall St. Rank hold ZBH as of Q1 2018.

  • Paragon Associates & Paragon Associates II Joint Venture reported no remaining Zimmer Biomet position as of Q1 2018 after selling out during the quarter.
  • Paragon Associates & Paragon Associates II Joint Venture sold 15,450 Zimmer Biomet shares in Q1 2018, an estimated $1.81M.
  • Paragon Associates & Paragon Associates II Joint Venture first reported a position in Zimmer Biomet in Q3 2017 and held it in 2 quarters.
  • Paragon Associates & Paragon Associates II Joint Venture's Zimmer Biomet position peaked at $1.81M in Q4 2017.
  • 876 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2018.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q1 2018, filed 15 May 2018.